Browse the corpus

Proteins constitute essential biomolecules with biological functions, including catalysis, signaling, and structural support, that depend on their 3-dimensional conformations.[1] Protein structure is organized hierarchically into primary (amino acid sequence), secondary (local motifs such as α-helices and β-sheets), tertiary (overall fold of a single polypeptide chain), and quaternary (assembly of multiple subunits) levels.[2][3][4][5][6] Among these levels, tertiary structure determines functional specificity and contributes to cellular stability. Tertiary folding is stabilized primarily by noncovalent interactions and is highly sensitive to mutations, misfolding, and environmental stress. Alterations in tertiary structure are implicated in diverse pathologies, including neurodegenerative diseases, cancer, and inherited protein misfolding disorders. This activity examines the biochemical principles underlying tertiary protein structure, the factors governing its formation, and the clinical consequences of structural alterations.

Protein Misfolding Diseases Many neurodegenerative and systemic disorders are driven by protein misfolding and subsequent aggregation. Despite involving distinct proteins, these conditions share a characteristic feature: the accumulation of amyloid fibrils and other aggregated protein deposits.[56] This commonality indicates a convergent pathological mechanism in which an initial trigger, such as a genetic mutation or spontaneous misfolding event, initiates a cascade of aggregation, cellular dysfunction, and tissue degeneration. Recognition of this shared pathway provides therapeutic opportunities, enabling the development of broad-spectrum strategies that target common mechanisms rather than individual, disease-specific proteins.[57] Prion Diseases Prion diseases, also known as transmissible spongiform encephalopathies, constitute a distinct class of fatal neurodegenerative disorders caused by infectious misfolded proteins. In these conditions, misfolded prion protein (PrP^Sc^) induces conformational conversion of the normal cellular isoform (PrP^C^) into the pathogenic structure. This process is hypothesized to be facilitated by an unidentified cellular factor, termed “protein X,” which brings PrP^C^ and PrP^Sc^ into proximity to promote misfolding. The pathogenic PrP^Sc^ isoform exhibits marked resistance to proteolytic degradation, resulting in accumulation as amyloid fibrils within the brain and other affected tissues. These deposits produce the characteristic spongiform vacuolation, neuronal loss, and progressive cell death that define transmissible spongiform encephalopathies. Representative examples include scrapie in sheep, chronic wasting disease in deer, bovine spongiform encephalopathy in cattle, and Creutzfeldt-Jakob disease in humans.[58] Prion diseases are transmissible through ingestion of contaminated material or iatrogenic exposure, such as via surgical instruments. The remarkable structural stability of prions confers resistance to conventional chemical and physical denaturation, creating significant challenges for sterilization and containment. All recognized prion diseases are progressive, currently untreatable, and universally fatal.[59] Neurodegenerative Diseases

Prion diseases are transmissible through ingestion of contaminated material or iatrogenic exposure, such as via surgical instruments. The remarkable structural stability of prions confers resistance to conventional chemical and physical denaturation, creating significant challenges for sterilization and containment. All recognized prion diseases are progressive, currently untreatable, and universally fatal.[59] Neurodegenerative Diseases Misfolded proteins are central to a broad class of neurodegenerative disorders, many of which progress via prion-like mechanisms. In these conditions, a misfolded protein functions as a nucleating seed, inducing the misfolding and aggregation of normally folded counterparts and spreading pathology throughout the nervous system in a self-perpetuating manner. In Alzheimer disease, 2 hallmark protein aggregates are observed: extracellular amyloid plaques and intracellular neurofibrillary tangles. Amyloid plaques are composed primarily of amyloid-β (Aβ) peptides, generated through sequential cleavage of the amyloid precursor protein by β-secretase and γ-secretase. The amyloid-β42 (Aβ42) isoform exhibits a high propensity for aggregation due to its hydrophobic properties. Although dense fibrils constitute plaques, soluble amyloid-β oligomers are currently considered the most neurotoxic species. Neurofibrillary tangles arise from hyperphosphorylated τ protein, which, under normal conditions, stabilizes microtubules within neurons. In Alzheimer disease, τ detaches from microtubules, misfolds, and aggregates, impairing axonal transport and disrupting synaptic integrity. Evidence indicates a synergistic interaction between amyloid-β and τ, in which amyloid-β accumulation may initiate or accelerate τ pathology, culminating in widespread synaptic dysfunction, neuronal loss, and the cognitive decline characteristic of dementia.[60]

Neurofibrillary tangles arise from hyperphosphorylated τ protein, which, under normal conditions, stabilizes microtubules within neurons. In Alzheimer disease, τ detaches from microtubules, misfolds, and aggregates, impairing axonal transport and disrupting synaptic integrity. Evidence indicates a synergistic interaction between amyloid-β and τ, in which amyloid-β accumulation may initiate or accelerate τ pathology, culminating in widespread synaptic dysfunction, neuronal loss, and the cognitive decline characteristic of dementia.[60] In Parkinson disease, the primary pathological hallmark is the aggregation of α-synuclein into intracellular inclusions known as Lewy bodies. These inclusions disrupt cellular homeostasis and precipitate the degeneration of dopaminergic neurons in the substantia nigra, producing the characteristic motor deficits.[61][62] Huntington disease arises from an expanded polyglutamine repeat, encoded by consecutive cytosine-adenine-guanine (CAG) codons, within the huntingtin gene. The resulting mutant huntingtin protein forms toxic aggregates that accumulate predominantly in the striatum and cerebral cortex, driving progressive motor, cognitive, and psychiatric impairment.[63] Sickle Cell Anemia Sickle cell anemia illustrates how a single amino acid substitution can profoundly alter protein structure and function, producing systemic physiological effects. This monogenic disorder results from a point mutation in the β-globin gene, in which a polar glutamic acid is replaced by a nonpolar valine at codon 6 due to a cytosine-to-adenine transversion.[64] The substitution generates a hydrophobic patch on the surface of hemoglobin S. Under low-oxygen conditions, this valine interacts with hydrophobic regions on adjacent hemoglobin S molecules, promoting polymerization into rigid fibers. These fibers distort red blood cells into stiff, sickle-shaped forms, reducing their flexibility and impairing oxygen transport. The resulting vascular occlusion, ischemia, and pain crises, together with increased hemolysis, drive the clinical manifestations of the disease. Membrane damage caused by oxidative and mechanical stress further exacerbates pathology.

The substitution generates a hydrophobic patch on the surface of hemoglobin S. Under low-oxygen conditions, this valine interacts with hydrophobic regions on adjacent hemoglobin S molecules, promoting polymerization into rigid fibers. These fibers distort red blood cells into stiff, sickle-shaped forms, reducing their flexibility and impairing oxygen transport. The resulting vascular occlusion, ischemia, and pain crises, together with increased hemolysis, drive the clinical manifestations of the disease. Membrane damage caused by oxidative and mechanical stress further exacerbates pathology. Homozygous individuals experience severe symptoms, whereas heterozygous carriers, exhibiting sickle cell trait, are typically asymptomatic. This trait confers a selective advantage against malaria, accounting for its persistence in endemic regions.[65]